Found: 27
Select item for more details and to access through your institution.
Pharmacokinetics, Safety, and Tolerability of the Dual Inhibitor of Tumor Necrosis Factor‐α and Interleukin 17A, ABBV‐257, in Healthy Volunteers and Patients With Rheumatoid Arthritis.
- Published in:
- Clinical Pharmacology in Drug Development, 2019, v. 8, n. 4, p. 492, doi. 10.1002/cpdd.611
- By:
- Publication type:
- Article
Osteoarthritis patients with pain improvement are highly likely to also have improved quality of life and functioning. A post hoc analysis of a clinical trial.
- Published in:
- Scandinavian Journal of Pain, 2016, v. 13, p. 175, doi. 10.1016/j.sjpain.2016.07.002
- By:
- Publication type:
- Article
Izokibep for the treatment of moderate-to-severe plaque psoriasis: a phase II, randomized, placebo-controlled, double-blind, dose-finding multicentre study including long-term treatment.
- Published in:
- British Journal of Dermatology, 2023, v. 189, n. 4, p. 381, doi. 10.1093/bjd/ljad186
- By:
- Publication type:
- Article
Dual-Energy Computed Tomography Has Additional Prognostic Value Over Clinical Measures in Gout Including Tophi: A Systematic Literature Review.
- Published in:
- Journal of Rheumatology, 2022, v. 40, n. 11, p. 1256, doi. 10.3899/jrheum.211246
- By:
- Publication type:
- Article
Pegloticase in Combination With Methotrexate in Patients With Uncontrolled Gout: A Multicenter, Open-label Study (MIRROR).
- Published in:
- 2021
- By:
- Publication type:
- journal article
SEX DIFFERENCES AMONG PHYSICIANS IN RURAL PRACTICE.
- Published in:
- Canadian Medical Association Journal (CMAJ), 1996, v. 154, n. 3, p. 303
- By:
- Publication type:
- Article
Exposure–response analyses demonstrate no evidence of interleukin 17A contribution to efficacy of ABT-122 in rheumatoid or psoriatic arthritis.
- Published in:
- Rheumatology, 2019, v. 58, n. 2, p. 352, doi. 10.1093/rheumatology/key312
- By:
- Publication type:
- Article
Dual inhibition of tumour necrosis factor and interleukin-17A with ABT-122: open-label long-term extension studies in rheumatoid arthritis or psoriatic arthritis.
- Published in:
- Rheumatology, 2018, v. 57, n. 11, p. 1972, doi. 10.1093/rheumatology/key173
- By:
- Publication type:
- Article
Inadequate pain relief and large functional loss among patients with knee osteoarthritis: evidence from a prospective multinational longitudinal study of osteoarthritis real-world therapies.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Inadequate pain relief and large functional loss among patients with knee osteoarthritis: evidence from a prospective multinational longitudinal study of osteoarthritis real-world therapies.
- Published in:
- Rheumatology, 2015, v. 54, n. 2, p. 270, doi. 10.1093/rheumatology/keu332
- By:
- Publication type:
- Article
Elagolix reduced dyspareunia and improved health-related quality of life in premenopausal women with endometriosis-associated pain.
- Published in:
- Journal of Endometriosis & Pelvic Pain Disorders, 2019, v. 11, n. 4, p. 171, doi. 10.1177/2284026519872401
- By:
- Publication type:
- Article
Bioequivalence of Liquid and Reconstituted Lyophilized Etanercept Subcutaneous Injections.
- Published in:
- Journal of Clinical Pharmacology, 2006, v. 46, n. 6, p. 654, doi. 10.1177/0091270006287705
- By:
- Publication type:
- Article
Incarceration and veterans of the first Gulf War.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Incarceration and Veterans of the First Gulf War.
- Published in:
- Military Medicine, 2005, v. 170, n. 7, p. 612, doi. 10.7205/MILMED.170.7.612
- By:
- Publication type:
- Article
Reducing Immunogenicity of Pegloticase With Concomitant Use of Mycophenolate Mofetil in Patients With Refractory Gout: A Phase II, Randomized, Double‐Blind, Placebo‐Controlled Trial.
- Published in:
- Arthritis & Rheumatology, 2021, v. 73, n. 8, p. 1523, doi. 10.1002/art.41731
- By:
- Publication type:
- Article
ABT‐122, a Bispecific Dual Variable Domain Immunoglobulin Targeting Tumor Necrosis Factor and Interleukin‐17A, in Patients With Rheumatoid Arthritis With an Inadequate Response to Methotrexate.
- Published in:
- Arthritis & Rheumatology, 2018, v. 70, n. 11, p. 1710, doi. 10.1002/art.40580
- By:
- Publication type:
- Article
Phase II Study of ABT‐122, a Tumor Necrosis Factor– and Interleukin‐17A–Targeted Dual Variable Domain Immunoglobulin, in Patients With Psoriatic Arthritis With an Inadequate Response to Methotrexate.
- Published in:
- Arthritis & Rheumatology, 2018, v. 70, n. 11, p. 1778, doi. 10.1002/art.40579
- By:
- Publication type:
- Article
A randomized, clinical trial to assess the relative efficacy and tolerability of two doses of etoricoxib versus naproxen in patients with ankylosing spondylitis.
- Published in:
- BMC Musculoskeletal Disorders, 2016, v. 17, p. 1, doi. 10.1186/s12891-016-1275-5
- By:
- Publication type:
- Article
Evaluation of two doses of etoricoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment of Rheumatoid Arthritis in a double-blind, randomized controlled trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Effects of Short Versus Long Bouts of Aerobic Exercise in Sedentary Women With Fibromyalgia: A Randomized Controlled Trial.
- Published in:
- Physical Therapy, 2003, v. 83, n. 4, p. 340, doi. 10.1093/ptj/83.4.340
- By:
- Publication type:
- Article
Mental health comorbidity patterns and impact on quality of life among veterans serving during the first Gulf War.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Do COX-2 inhibitors provide additional pain relief and anti-inflammatory effects in patients with rheumatoid arthritis who are on biological disease-modifying anti-rheumatic drugs and/or corticosteroids? Post-hoc analyses from a randomized clinical trial with etoricoxib
- Published in:
- BMC Musculoskeletal Disorders, 2015, v. 16, n. 1, p. 1, doi. 10.1186/s12891-015-0468-7
- By:
- Publication type:
- Article
Do COX-2 inhibitors provide additional pain relief and anti-inflammatory effects in patients with rheumatoid arthritis who are on biological disease-modifying anti-rheumatic drugs and/or corticosteroids? Post-hoc analyses from a randomized clinical trial with etoricoxib.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Evaluation of etoricoxib in patients undergoing total knee replacement surgery in a double-blind, randomized controlled trial.
- Published in:
- BMC Musculoskeletal Disorders, 2013, v. 14, n. 1, p. 1, doi. 10.1186/1471-2474-14-300
- By:
- Publication type:
- Article
Evaluation of etoricoxib in patients undergoing total knee replacement surgery in a double-blind, randomized controlled trial.
- Published in:
- 2013
- By:
- Publication type:
- journal article
A multicentre, efficacy and safety study of methotrexate to increase response rates in patients with uncontrolled gout receiving pegloticase (MIRROR): 12-month efficacy, safety, immunogenicity, and pharmacokinetic findings during long-term extension of an open-label study
- Published in:
- Arthritis Research & Therapy, 2022, v. 24, n. 1, p. 1, doi. 10.1186/s13075-022-02865-z
- By:
- Publication type:
- Article
Blood Pressure and Cardiovascular Outcomes in Patients Taking Nonsteroidal Antiinflammatory Drugs.
- Published in:
- Cardiovascular Therapeutics, 2012, v. 30, n. 6, p. 342, doi. 10.1111/j.1755-5922.2011.00283.x
- By:
- Publication type:
- Article